Anisomycin, Protein synthesis inhibitor
Be the first to review this product! Submit a review
|
(4 Publications)
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anisomycin, Protein synthesis inhibitor (AB120495)
ab6161 staining tubulin HeLa cells treated with anisomycin (ab120495), by ICC/IF. Increase in tubulin expression correlates with increased concentration of anisomycin as described in literature.
The cells were incubated at 37°C for 6h in media containing different concentrations of ab120495 (anisomycin) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab6161 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rat polyclonal antibody (ab98386) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
- Chemical Structure
Lab
Chemical Structure - Anisomycin, Protein synthesis inhibitor (AB120495)
2D chemical structure image of ab120495, Anisomycin, Protein synthesis inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
eLife 10: PubMed33781382
2021
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasia (New York, N.Y.) 19:354-363 PubMed28319809
2017
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 5:8733 PubMed25736434
2015
Applications
Unspecified application
Species
Unspecified reactive species
Science signaling 6:ra81 PubMed24023255
2013
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com